To assess the function of SEC23B on tumor progression, we established a SEC23B-knockout (KO) cell line using CRISPR technique, and validated the down-regulation of SEC23B with sequencing (Fig. 3b) and immunoblotting (Fig. 3c). Here, SEC23B is linked to neoplasm.